Paldánius Päivi M, Ivaska Kaisa K, Mäkitie Outi, Viljakainen Heli
Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland.
Front Pediatr. 2021 Aug 24;9:610227. doi: 10.3389/fped.2021.610227. eCollection 2021.
Children and adolescents have high bone turnover marker (BTM) levels due to high growth velocity and rapid bone turnover. Pediatric normative values for BTMs reflecting bone formation and resorption are vital for timely assessment of healthy bone turnover, investigating skeletal diseases, or monitoring treatment outcomes. Optimally, clinically feasible measurement protocols for BTMs would be validated and measurable in both urine and serum. We aimed to (a) establish sex- and age-specific reference intervals for urinary and serum total and carboxylated osteocalcin (OC) in 7- to 19-year-old healthy Finnish children and adolescents ( = 172), (b) validate these against standardized serum and urinary BTMs, and (c) assess the impact of anthropometry, pubertal status, and body composition on the OC values. All OC values in addition to other BTMs increased with puberty and correlated with pubertal growth, which occurred and declined earlier in girls than in boys. The mean serum total and carboxylated OC and urinary OC values and percentiles for sex-specific age categories and pubertal stages were established. Correlation between serum and urinary OC was weak, especially in younger boys, but improved with increasing age. The independent determinants for OC varied, the urinary OC being the most robust while age, height, weight, and plasma parathyroid hormone (PTH) influenced serum total and carboxylated OC values. Body composition parameters had no influence on any of the OC values. In children and adolescents, circulating and urinary OC reflect more accurately growth status than bone mineral density (BMD) or body composition. Thus, validity of OC, similar to other BTMs, as a single marker of bone turnover, remains limited. Yet, serum and urinary OC similarly to other BTMs provide a valuable supplementary tool when assessing longitudinal changes in bone health with repeat measurements, in combination with other clinically relevant parameters.
由于生长速度快和骨转换迅速,儿童和青少年的骨转换标志物(BTM)水平较高。反映骨形成和骨吸收的BTM的儿科标准值对于及时评估健康的骨转换、研究骨骼疾病或监测治疗结果至关重要。理想情况下,临床上可行的BTM测量方案应在尿液和血清中均得到验证且可测量。我们旨在:(a)为7至19岁健康芬兰儿童和青少年(n = 172)建立尿和血清总骨钙素及羧化骨钙素(OC)的性别和年龄特异性参考区间;(b)对照标准化血清和尿BTM对这些参考区间进行验证;(c)评估人体测量学、青春期状态和身体成分对OC值的影响。除其他BTM外,所有OC值均随青春期而增加,并与青春期生长相关,女孩青春期生长开始和结束的时间早于男孩。确定了特定性别年龄类别和青春期阶段的血清总骨钙素和羧化骨钙素以及尿OC值的平均值和百分位数。血清和尿OC之间的相关性较弱,尤其是在年龄较小的男孩中,但随着年龄增长而改善。OC的独立决定因素各不相同,尿OC最为稳定,而年龄、身高、体重和血浆甲状旁腺激素(PTH)影响血清总骨钙素和羧化骨钙素值。身体成分参数对任何OC值均无影响。在儿童和青少年中,循环和尿OC比骨矿物质密度(BMD)或身体成分更准确地反映生长状态。因此,与其他BTM一样,OC作为骨转换单一标志物的有效性仍然有限。然而,与其他BTM类似,血清和尿OC在结合其他临床相关参数进行重复测量以评估骨健康的纵向变化时,提供了一个有价值的补充工具。